Clinical Trials Directory

Trials / Conditions / Junctional Epidermolysis Bullosa

Junctional Epidermolysis Bullosa

9 registered clinical trials studyying Junctional Epidermolysis Bullosa — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
NCT06594393
Xinnate ABPhase 2
RecruitingA Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis
NCT06917690
Chiesi Farmaceutici S.p.A.Phase 3
Active Not RecruitingPilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa
NCT06713434
Fundación DEBRA Chile, Niños Piel de CristalPhase 1
UnknownGenotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268
University Hospital Birmingham NHS Foundation Trust—
UnknownOptimizing IV Gentamicin in JEB
NCT04140786
University of Southern CaliforniaPhase 1 / Phase 2
TerminatedEvaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis
NCT03578029
Lenus Therapeutics, LLCPhase 2
RecruitingGentamicin for Junctional Epidermolysis Bullosa
NCT03526159
University of Southern CaliforniaPhase 1 / Phase 2
CompletedTo Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullos
NCT03472287
Castle Creek Pharmaceuticals, LLCPhase 1
TerminatedClinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem
NCT03490331
Holostem s.r.l.Phase 1 / Phase 2